Abbott to cease sale of infant probiotic products after FDA warning 27/10/2023 (VOVWORLD) - Abbott Laboratories will stop sales of its Similac Probiotic Tri-Blend product used for hospitalized preterm infants after the U.S. Food and Drug Administration issued a warning letter,...